Hoofddorp, The Netherlands, 6 June 2019. IGEA Pharma N.V. (the “Company” and together with its subsidiaries “IGEA” or the “Group”) today announced that the annual general meeting followed all recommendations of the Company.
Press releases/News
IGEA discloses its Q1 2019 financials
Hoofddorp, The Netherlands, 27 May 2019. IGEA Pharma N.V. (the “Company” and together with its subsidiaries “IGEA” or the “Group”) today announced the disclosure of its Q1 2019 financials.
IGEA discloses its Annual Report 2018
Hoofddorp, The Netherlands, 30 April 2019. IGEA Pharma N.V. (the “Company” and together with its subsidiaries “IGEA” or the “Group”) today announced the disclosure of its Annual Report 2018.
Highlights
Update of the corporate calendar
Hoofddorp, the Netherlands, 28 March 2019. IGEA Pharma N.V. (SIX: IGPH) today announced an update of its corporate calendar. The annual general meeting is newly set-up for 27 May 2019. The presentation of the 2018 financials and the Q1 2019 financials is newly set-up for 26 April 2019 and 27 May 2019 respectively. The update is due to some additional work necessary to harmonize with SIX and Dutch disclosure requirements. The updated corporate calendar is available under igeapharma.nl/investors-relations/
Listing of IGEA Pharma N.V.
Amsterdam, December 17, 2018. IGEA Pharma N.V. announced today that it will list all of its ordinary shares on SIX Swiss Exchange as of December 20, 2018 under the ticker symbol ‘IGPH’.